Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam · Delayed Price · Currency is VND 60,300
-300 (-0.50%)
At close: Nov 3, 2026
HNX:DP3 Revenue
Central Pharmaceutical Joint Stock Company No3 had revenue of 129.40B VND in the quarter ending September 30, 2026, with 7.63% growth. This brings the company's total for the last twelve months to 524.41B, up 24.11% year-over-year. In the year 2025, Central Pharmaceutical Joint Stock Company No3 had annual revenue of 437.93B with 4.90% growth. That makes Central Pharmaceutical Joint Stock Company No3 the 33,750th largest company in the world by revenue and 459th in Vietnam.
Revenue (ttm)
524.41B
Revenue Growth
+24.11%
P/S Ratio
2.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.30T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 437.93B | 20.44B | 4.90% |
| Jan 1, 2025 | 417.49B | 7.75B | 1.89% |
| Jan 1, 2024 | 409.73B | -75.34B | -15.53% |
| Dec 31, 2022 | 485.07B | 104.00B | 27.29% |
| Dec 31, 2021 | 381.08B | -14.64B | -3.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.77T |
| Ha Tay Pharmaceutical JSC | 2.38T |
| Imexpharm | 2.29T |
| Domesco Medical Import - Export Joint-Stock | 2.17T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.89T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.15T |
| Vidipha Central Pharmaceutical JSC | 1.01T |
Central Pharmaceutical Joint Stock Company No3 News
- 14 days ago - Central Pharmaceutical Joint Stock Company No3 Quarterly report: Q3 2026 - Filings
- 3 months ago - Central Pharmaceutical Joint Stock Company No3 Quarterly report: Q2 2026 - Filings
- 6 months ago - Central Pharmaceutical Joint Stock Company No3 Quarterly report: Q1 2026 - Filings
- 9 months ago - Central Pharmaceutical Joint Stock Company No3 Quarterly report: Q4 2025 - Filings